Corgenix Ebola Rapid Test Publicity

The Corgenix point-of-care (POC) rapid test kit for the Ebola virus (ReEBOV) is designed to be used in any clinical or field lab to determine in a matter of minutes if a patient is infected with Ebola. As a result, this test can be more effective than other tests at fighting the spread of this highly contagious disease. Incorporating Armada’s years of experience marketing several products for Corgenix Medical Corporation, including diagnostic tests, our team was able to collaborate closely with the client and with partner organizations on developing compelling messaging for consumer and business audiences to help build awareness. Armada successfully exceeded publicity goals for this client, simultaneously achieving publicity aligned with the company’s vision and mission while increasing overall awareness of Corgenix, which was little known outside of the immediate Boulder/Broomfield area prior to our campaign.

Highlights of placements achieved include: The New York Times, National Public Radio, Associated Press, Science Magazine, Denver Post and television news stories which included CNBC and local coverage on KMGH Channel 7 and KUSA Channel 9.